Digital Edition: Market Pathways February 2024

article image

The EU's proposed product liability directive portends potentially significant risk to medtechs that market their products in Europe; FDA's game plan for its one-year chairmanship of the International Medical Device Regulators Forum management committee; Siemens pushes lawmakers hard for more predictable reimbursement of AI-based tools; MDMA's Mark Leahey on the year ahead in medtech; and practical go-to-market tips from US, EU and UK regulatory experts.


This article is restricted to subscribers only.

Sign in to continue reading.


We're here to help! Please contact us at: